Assessment of EGFR Mutation Status in Needle Biopsies and Cytology Specimens of Lung Adenocarcinoma by Immunohistochemistry Using Antibodies to the Two Major Forms of Mutant EGFR

被引：0
|
作者：
Ang, D. C. [1 ]
Brevet, M. [1 ]
Ladanyi, M. [1 ]
Zakowski, M. F. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
382
引用
收藏
页码：87A / 87A
页数：1
相关论文
共 49 条
  • [41] High concordance of EGFR mutation status between sputum and corresponding tissue specimens of late-stage lung cancers using amplification refractory mutation system-PCR
    Su, Fei
    Fu, Yiyun
    Wu, Qian
    Zheng, Ke
    Tang, Yuan
    Su, Xueying
    Wang, Ye
    Jiang, Lili
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (05): : 2683 - 2690
  • [42] Novel EGFR mutation-specific antibodies for lung adenocarcinoma: Highly specific but not sensitive detection of an E746_A750 deletion in exon 19 and an L858R mutation in exon 21 by immunohistochemistry
    Seo, An Na
    Park, Tae-In
    Jin, Yan
    Sun, Ping-Li
    Kim, Hyojin
    Chang, Hyun
    Chung, Jin-Haeng
    LUNG CANCER, 2014, 83 (03) : 316 - 323
  • [43] Prediction of EGFR Mutation Status Based on 18F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma
    Yin, Guotao
    Wang, Ziyang
    Song, Yingchao
    Li, Xiaofeng
    Chen, Yiwen
    Zhu, Lei
    Su, Qian
    Dai, Dong
    Xu, Wengui
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [44] Immunohistochemistry detection of epidermal growth factor receptor (EGFR) exons 19 and 21 mutations in non-small cell lung cancer (NSCLC) using novel mutation specific antibodies
    Kato, Y.
    Peled, N.
    Yoshida, K.
    Wynes, A. W.
    Pardo, A.
    Mascaux, C. J.
    Tsubol, M.
    Ohira, T.
    Ikeda, N.
    Hirsch, F. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma
    Ali, Greta
    Bruno, Rossella
    Giordano, Mirella
    Prediletto, Irene
    Marconi, Letizia
    Zupo, Simonetta
    Fedeli, Franco
    Ribechini, Alessandro
    Chella, Antonio
    Fontanini, Gabriella
    ONCOLOGY LETTERS, 2016, 12 (05) : 4009 - 4012
  • [46] Prediction of EGFR Mutation Status Based on 18F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma (vol 11, 709137, 2021)
    Yin, Guotao
    Wang, Ziyang
    Song, Yingchao
    Li, Xiaofeng
    Chen, Yiwen
    Zhu, Lei
    Su, Qian
    Dai, Dong
    Xu, Wengui
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] Prediction of epidermal growth factor receptor (EGFR) mutation status in lung adenocarcinoma patients on computed tomography (CT) images using 3-dimensional (3D) convolutional neural network
    Zhang, Guojin
    Shang, Lan
    Cao, Yuntai
    Zhang, Jing
    Li, Shenglin
    Qian, Rong
    Liu, Huan
    Zhang, Zhuoli
    Pu, Hong
    Man, Qiong
    Kong, Weifang
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2024, 14 (08)
  • [48] Detection of BRAF Mutations in EGFR and ALK negative Lung Adenocarcinoma Using BRAF V600E Mutation-Specific Antibody: A Retrospective Study and Correlation with DNA-based analysis of BRAF Gene Status
    Harrell, Michael W.
    Buehler, Karen
    Vasef, Mohammad
    LABORATORY INVESTIGATION, 2018, 98 : 733 - 734
  • [49] Detection of BRAF Mutations in EGFR and ALK negative Lung Adenocarcinoma Using BRAF V600E Mutation-Specific Antibody: A Retrospective Study and Correlation with DNA-based analysis of BRAF Gene Status
    Harrell, Michael W.
    Buehler, Karen
    Vasef, Mohammad
    MODERN PATHOLOGY, 2018, 31 : 733 - 734
12345